Evidence map›Paper›PMID 21129337›Full record

Trial reportJournal of diabetes science and technology2010

Design and clinical pilot testing of the model-based dynamic insulin sensitivity and secretion test (DISST).

Thomas F Lotz, J Geoffrey Chase, Kirsten A McAuley, Geoffrey M Shaw, Paul D Docherty, Juliet E Berkeley, Sheila M Williams, Christopher E Hann, Jim I Mann

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of diabetes science and technology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Variability in Estimated Modelled Insulin Secretion.Journal of diabetes science and technology · 2022
    Article
  8. Estimating Increased EGP During Stress Response in Critically Ill Patients.Journal of diabetes science and technology · 2021
    Article
  9. Article
  10. Levels and Diagnostic Value of Model-based Insulin Sensitivity in Sepsis: A Preliminary Study.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2018
    Article
  11. Article
  12. Untangling glycaemia and mortality in critical care.Critical care (London, England) · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Characterisation of the iterative integral parameter identification method.Medical & biological engineering & computing · 2012
    Article
  17. A spectrum of dynamic insulin sensitivity test protocols.Journal of diabetes science and technology · 2011
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Thomas F LotzCentre for Bioengineering, University of Canterbury, and Department of Intensive Medicine, Christchurch Hospital, Christchurch, New Zealand.
J Geoffrey Chase
Kirsten A McAuley
Geoffrey M Shaw
Paul D Docherty
Juliet E Berkeley
Sheila M Williams
Christopher E Hann
Jim I Mann
University of Canterbury · NZUniversity of Otago · NZChristchurch Hospital · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInsulin resistance is a significant risk factor in the pathogenesis of type 2 diabetes. This article presents pilot study results of the dynamic insulin sensitivity and secretion test (DISST), a high-resolution, low-intensity test to diagnose insulin sensitivity (IS) and characterize pancreatic insulin secretion in response to a (small) glucose challenge. This pilot study examines the effect of glucose and insulin dose on the DISST, and tests its repeatability.

methodsDISST tests were performed on 16 subjects randomly allocated to low (5 g glucose, 0.5 U insulin), medium (10 g glucose, 1 U insulin) and high dose (20 g glucose, 2 U insulin) protocols. Two or three tests were performed on each subject a few days apart.

resultsAverage variability in IS between low and medium dose was 10.3% (p=.50) and between medium and high dose 6.0% (p=.87). Geometric mean variability between tests was 6.0% (multiplicative standard deviation (MSD) 4.9%). Geometric mean variability in first phase endogenous insulin response was 6.8% (MSD 2.2%). Results were most consistent in subjects with low IS.

conclusionsThese findings suggest that DISST may be an easily performed dynamic test to quantify IS with high resolution, especially among those with reduced IS.

Indexed as

GlucoseGlucose Tolerance TestInsulinInsulin ResistanceResearch DesignAdultBiomarkersBlood GlucoseC-PeptideDiabetes Mellitus, Type 2Feasibility StudiesFemaleHumansMaleMiddle AgedNew ZealandBiomarkersBlood GlucoseC-PeptideGlucoseInsulin

Identifiers

PMID21129337
PMCPMC3005052
OpenAlexW2024959810

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.